Portfolio concentration
As of February 27, 2026 · N-PORT
Holdings
162
Top-10 weight
46.60%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
27
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1268.6
Holdings
As of February 27, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 704,342 | $740.96M | 11.34% |
| 2 | JOHNSON&JOHNSON | — | 2,688,331 | $667.86M | 10.22% |
| 3 | ABBVIE INC | — | 1,157,700 | $268.68M | 4.11% |
| 4 | GILEAD SCIENCES INC | — | 1,736,422 | $258.64M | 3.96% |
| 5 | MERCK & CO | — | 1,871,806 | $231.77M | 3.55% |
| 6 | AMGEN INC | — | 588,158 | $228.30M | 3.49% |
| 7 | UNITEDHEALTH GRP | — | 677,911 | $198.81M | 3.04% |
| 8 | INTUITIVE SURGICAL INC | — | 319,051 | $160.65M | 2.46% |
| 9 | ABBOTT LABS | — | 1,361,894 | $158.46M | 2.43% |
| 10 | DANAHER CORP | — | 716,192 | $150.86M | 2.31% |
| 11 | THERMO FISHER SCIENTIFIC INC | — | 285,286 | $148.67M | 2.28% |
| 12 | EDWARDS LIFESCIENCES CORP | — | 1,710,975 | $147.95M | 2.26% |
| 13 | VERTEX PHARMACEUTICALS INC | — | 273,318 | $135.79M | 2.08% |
| 14 | MEDTRONIC PLC | — | 1,336,319 | $130.50M | 2.00% |
| 15 | STRYKER CORP | — | 333,071 | $129.05M | 1.98% |
| 16 | TEVA PHARMACEUTICAL IND ADR | — | 3,475,093 | $117.67M | 1.80% |
| 17 | CENCORA INC | — | 265,860 | $98.94M | 1.51% |
| 18 | BOSTON SCIENTIFIC CORP | — | 1,284,362 | $98.70M | 1.51% |
| 19 | ASTRAZENECA PLC | — | 449,772 | $94.65M | 1.45% |
| 20 | ARGENX SE SPONSORED ADR | — | 121,340 | $93.06M | 1.42% |
| 21 | MCKESSON CORP | — | 79,662 | $78.66M | 1.20% |
| 22 | ROCHE HOLDINGS AG (GENUSSCHEINE) | — | 147,789 | $70.33M | 1.08% |
| 23 | BIOGEN INC | — | 364,188 | $69.86M | 1.07% |
| 24 | ALNYLAM PHARMACEUTICALS INC | — | 207,149 | $68.96M | 1.06% |
| 25 | REGENERON PHARMACEUTICALS INC | — | 87,659 | $68.52M | 1.05% |
| 26 | BRISTOL-MYERS SQUIBB CO | — | 1,097,084 | $68.43M | 1.05% |
| 27 | HCA HEALTHCARE INC | — | 125,705 | $66.59M | 1.02% |
| 28 | BlackRock Cash Funds: Institutional, SL Agency Shares | BISXX | 57,435,421 | $57.46M | 0.88% |
| 29 | EXACT SCIENCES CORP | — | 548,069 | $56.66M | 0.87% |
| 30 | RHYTHM PHARMACEUTICALS INC | — | 538,793 | $49.96M | 0.76% |
| 31 | IDEXX LABS INC | — | 74,621 | $49.01M | 0.75% |
| 32 | DEXCOM INC | — | 663,769 | $48.74M | 0.75% |
| 33 | PENUMBRA INC | — | 133,216 | $45.88M | 0.70% |
| 34 | INSMED INC | — | 301,353 | $45.00M | 0.69% |
| 35 | Novartis AG | — | 251,660 | $42.43M | 0.65% |
| 36 | INCYTE CORP | — | 396,174 | $40.12M | 0.61% |
| 37 | MEDLINE INC-A | — | 842,573 | $40.03M | 0.61% |
| 38 | WATERS CORP | — | 124,449 | $39.75M | 0.61% |
| 39 | BLKR-LIQ T-INS | TSTXX | 34,195,870 | $34.20M | 0.52% |
| 40 | PROTAGONIST THERAPEUTICS INC | — | 370,408 | $34.11M | 0.52% |
| 41 | AGILENT TECHNOLOGIES INC | — | 271,239 | $32.92M | 0.50% |
| 42 | PFIZER INC | — | 1,184,622 | $32.75M | 0.50% |
| 43 | NUVALENT INC-A | — | 315,841 | $32.20M | 0.49% |
| 44 | COGENT BIOSCIENCES INC | — | 820,419 | $31.87M | 0.49% |
| 45 | GUARDANT HEALTH INC | — | 336,665 | $31.61M | 0.48% |
| 46 | REVOLUTION MEDICINES INC | — | 302,995 | $30.91M | 0.47% |
| 47 | MODERNA INC | — | 560,799 | $30.04M | 0.46% |
| 48 | GALDERMA GROUP A | — | 153,331 | $28.94M | 0.44% |
| 49 | CVS HEALTH CORP | — | 359,282 | $28.71M | 0.44% |
| 50 | ELEVANCE HEALTH INC | — | 88,605 | $28.35M | 0.43% |
1 / 4
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.